Home › Pharmaceuticals › Therapeutic/drugs
Therapeutic/drugs Market Research Reports & Consulting
The drug manufacturers are suffering due to raising costs attributed to increasing complexities in clinical trials. Hence speedy adoption of new technologies is very essential for market players to optimize their costs and to have a competitive edge in the market. Innovation in breakthrough technologies has widened the market scope for therapeutics and drugs market. There has been signification shift in focus from providing general drugs and therapy to providing drugs for target cluster and personalized therapies. This is attributed to market transition from pharmaceutical to biotechnology. Enhancing technologies impacting high growth markets such as proteomics, genomics, and personalized medicines have led a long way in introducing effective drugs and therapies. Increasing regulations imposed on drug development process have created a demand for automated tools such as bioinformatics that can store analytical data and facilitate the researcher to design and develop effective drugs. Entry of generic drugs that are less expensive has posed threat to the market players in the drugs market. Increasing safety requirement and legislation is furthermore adding pressure on the drug and therapy providers to increase efficiency. Enhancing Drug development technologies and emerging concepts in life sciences have a greater role in such complicated environment. see less
The drug manufacturers are suffering due to raising costs attributed to increasing complexities in clinical trials. Hence speedy adoption of new technologies is very essential for market players to optimize their costs and to have a competitive edge in the market. Innovation in breakthrough technolo ....see more
Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, Lubricant, Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021
The global pharmaceutical excipients market is projected to reach USD 8.1 Billion in 2021 at a CAGR of 6.1% in the forecast period 2016 to 2021. The rising demand for newer & improved drugs, development of new drug delivery systems, and greater understanding of the functional benefits of excipients are positively impacting the overall growth of the market.
|June 2016||$ 5650|
Fetal (Labor & Delivery) and Neonatal Care Equipment Market - (Ultrasound, Doppler, Monitors (Intrapartum & Antepartum), Warmer, Incubator, Pulse Oximeter, Phototherapy/Jaundice Management Devices, CPAP, Capnograph, & Resuscitator) - Global Forecast to 2020
The global fetal (labor & delivery) and neonatal care equipment market is poised to grow at a CAGR of 6.5% during the forecast period, and is expected to reach a value of USD 8.61 Billion by 2020. Rising awareness among population in developing nations about neonatal and fetal care, growing number of NICU admissions and inflow of technologically advanced products are driving the growth of the fetal and neonatal care equipment market. In addition, factors such as increasing prevalence of hospital acquired infections in newborn babies and huge patient populations of preterm & low weight birth babies in both developed & developing markets demand for neonatal care equipment are further stimulating the growth of the fetal and neonatal care equipment market.
|February 2016||$ 5650|
Leukemia Therapeutics Market (Acute/Chronic Lymphocytic Leukemia & Acute/Chronic Myeloid Leukemia) Pipeline Forecast & Market Forecast in G8 Countries - Global Forecast to 2020
Leukemia is the type of blood cancer and the ninth most common one in males. It accounts for almost 0.0148% of all the men and 0.009% of all the women worldwide. The leukemia market is segmented into four types; namely acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. The market was dominated by chronic myeloid leukemia in 2010. However, in 2020, the market is expected to be equally dominated by acute lymphocytic leukemia and chronic myeloid leukemia.
|November 2013||$ 5650|
Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 – 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases)
Autologous cell therapies are new therapeutic intervention where it introduces or uses cells or tissues from the individual, cultured, expanded and re-introduced at the site of the disease of the donor. They are widely promoted as next pillar or advancement in medical care.
|October 2012||$ 5650|